CGTN: How China’s high-standard opening up fuels high-quality development
BEIJING, Nov. 8, 2025 /PRNewswire/ — Following President Xi Jinping’s visits to Hainan and Guangdong, CGTN published an article on China’s strategic... Read more.
New Data from REZOLVE-AD Study of Rezpegaldesleukin Presented in Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting
Statistically significant and clinically meaningful improvements in mean ACQ-5 scores were reported at week 16 versus placebo in patients who had atopic dermatitis... Read more.
Zinzino AB (publ.): Zinzino acquires Mexican company Sanki to increase distribution capacity in North America and South America
GOTHENBURG, Sweden, Nov. 8, 2025 /PRNewswire/ — Zinzino has signed an agreement with Mexico-based direct sales company Sanki to acquire the rights to the company’s... Read more.
AMGEN’S REPATHA® CUTS RISK OF FIRST MAJOR ADVERSE CARDIOVASCULAR EVENTS BY 25% IN LANDMARK PHASE 3 VESALIUS-CV TRIAL
Study Also Shows 36% Reduction in Risk of Heart Attack Repatha is the First and Only PCSK9 Inhibitor to Significantly Reduce the Risk of First Heart Attack and... Read more.
Vaughn College Hosts 11th Annual Manufacturing Day to Promote Career Opportunities and to Inspire the Next Generation of Engineering and Technology Professionals
The annual event hosted by Vaughn’s Engineering and Technology Department featuredpresentations from industry experts and STEM workshops for local community... Read more.
AusperBio Announces Late-Breaking 48-Week Phase II Data of AHB-137 in Chronic Hepatitis B at AASLD 2025
Pooled 48-week results from two Phase II studies show sustained antiviral responses and a favorable safety profile of AHB-137 in HBeAg-negative chronic hepatitis... Read more.
2025 World Internet Conference Wuzhen Summit Opens
BEIJING, Nov. 8, 2025 /PRNewswire/ — A news report from CRI Online: The 2025 World Internet Conference (WIC) Wuzhen Summit opened on November 7 in Wuzhen,... Read more.
SanegeneBio Announces RNAi Licensing and Research Collaboration with Lilly
-Companies will collaborate on RNAi research for metabolic disease targets BOSTON, Nov. 8, 2025 /PRNewswire/ — SanegeneBio, a clinical-stage biotechnology... Read more.
CHAI: $48M/Year in Revenue After Funding Round by AMD and CoreWeave
CHAI, the fast-rising social AI platform redefining human–AI interaction, has surpassed its 2025 revenue target two months ahead of schedule, reaching $48 million... Read more.
Sharing Prosperity in the Intelligent Era: 2025 China International Intelligent Communication Forum Held in Wuxi
WUXI, China, Nov. 7, 2025 /PRNewswire/ — On November 8th, the 2025 China International Intelligent Communication Forum, co-hosted by China Media Group (CMG)... Read more.